Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)

por Walker, David R., Pedrosa, Marcos C., Manthena, Shivaji R., Patel, Nikil, Marx, Steven E.
Publicado en Adv Ther (2015)

Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis

por Docherty, Matt, Regnier, Stephane A, Capkun, Gorana, Balp, Maria-Magdalena, Ye, Qin, Janssens, Nico, Tietz, Andreas, Löffler, Jürgen, Cai, Jennifer, Pedrosa, Marcos C, Schattenberg, Jörn M
Publicado en J Am Med Inform Assoc (2021)

U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

por Ho, Samuel B., Aqel, Bashar, Dieperink, Eric, Liu, Shanglei, Tetrick, Lori, Falck-Ytter, Yngve, DeComarmond, Charles, Smith, Coleman I., McKee, Daniel P., Boyd, William, Kulig, Clark C., Bini, Edmund J., Pedrosa, Marcos C.
Publicado 2011